James Kenneth Joseph Diss

Title: James Kenneth Joseph Diss: Innovator in Cancer Diagnosis and Treatment

Introduction

James Kenneth Joseph Diss is a notable inventor based in London, GB. He has made significant contributions to the field of cancer diagnosis and treatment. His innovative approach focuses on the detection and management of cancer, particularly prostate cancer.

Latest Patents

James Kenneth Joseph Diss holds a patent for a method of diagnosing cancer in human patients. This method involves obtaining a sample containing nucleic acid and/or protein from the patient. It also includes determining whether the sample contains a level of hNe—Na voltage-gated Na channel nucleic acid or protein associated with cancer. Additionally, he has developed a method of treating cancer by administering an agent that selectively prevents the function of hNe—Na voltage-gated Na channel. His genetic construct comprises a nucleic acid encoding a molecule capable of preventing the function of hNe—Na voltage-gated Na channel expressed in a cell. This innovative work is particularly suited for addressing prostate cancer.

Career Highlights

James Kenneth Joseph Diss is associated with Imperial College Innovations Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment methodologies.

Collaborations

James has collaborated with notable colleagues, including Mustafa Bilgin Ali Djamgoz and Scott Paton Fraser. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cancer care.

Conclusion

James Kenneth Joseph Diss is a pioneering inventor whose work in cancer diagnosis and treatment holds promise for improving patient outcomes. His contributions to the field are significant and reflect a commitment to advancing medical science.